In LUAD patients and KRAS mutant lung cancer mice, the mutant KRAS activated PI3K/STAT3 signal transduction, thus inhibiting the post-transcriptional inhibition of CD47 by miR-34a. This evidence concerns the gene KRAS and lung cancer.